Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Testosterone for Atrophic Vaginitis in Breast Cancer
NCT01122342Phase 2Suspended
- Sponsor
- The University of Vermont
- Start
- Dec 2006
- Primary completion
- Dec 2010
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of testosterone in atrophic vaginitis, sponsored by The University of Vermont. Primary endpoint: Serum estradiol levels at 28 days. Started Dec 2006; status: suspended.
02
Drugs
testosterone
03
Conditions
atrophic vaginitis
Beyond the preview
Go deeper on NCT01122342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01122342.